Belyntic develops Peptide Easy Clean (PEC), a proprietary purification technology that enables parallel peptide purification. PEC relies on an innovative catch-and-release purification between a novel linker molecule and a modified agarose filter material. The technology aims to provide a protocol for actors across the pharmaceutical value chain from research and development to production. Led by Andreas Regnery, Belyntic is a spin-off from the Humboldt-University of Berlin and is based in Berlin, Germany. The company completed a €1.3m seed financing round and plans to use the funds to develop new products and services. It intends to access clinical-stage projects and regulated market segments and to grow internationally.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

Sep 2019